Philosophiae Doctor - PhD / Solute carrier transporters belonging to the major facilitator family of membrane transporter are increasingly being recognized as a possible mechanism to explain inter-individual variation in drug efficacy and response. Genetic factors are estimated to be responsible for approximately 15-30% of inter-individual variation in drug disposition and response. The aims of this study were to determine the minor allele frequencies of 78 previously identified single nucleotide polymorphisms in the pharmacogenetically relevant SLC22A1-3 and SLC47A1 genes in the indigenous African population of South Africa. Secondly, to determine whether allele and genotype frequencies for these SNP were different from that reported for other African, Caucasian, and Asian populations. Thirdly, to infer haplotypes from the genetic information which can potentially be used in future to design and interpret results of pharmacogenetics association studies involving these genes and their substrate drugs. Finally, to determine whether the Xhosa population harbour novel SNPs in the SLC22A2 gene, that encodes the kidney-specific hOCT2. SNaPshot™ multiplex single base minisequencing systems were developed and optimized for each of SLC22A1, SLC22A2, SLC22A3, and SLC47A1 covering the previously identified 78 SNPs. These systems were then used to genotype the alleles of 148 healthy Xhosa subjects residing in Cape Town, South Africa. In addition, the proximal promoter region and all 11 exons and flanking regions of the SLC22A2 gene of 96 of the participants were screened for novel SNPs by direct sequencing. The Xhosa subjects investigated lacked heterozygosity and were monomorphic for 91% of the SNPs screened. None of the SLC22A3 and SLC47A1 SNPs investigated was observed in this study. Sequencing of the SLC22A2 gene revealed 28 SNPs, including seven novel polymorphic sites, in the 96 Xhosa subjects that were screened. The minor allele frequencies of the seven previously identified variant SNPs observed in this study were different compared to that observed for American and European Caucasian, and Asian populations. Moreover, the allele frequencies for these SNPs differed amongst African populations themselves. Eight and seven haplotypes were inferred for SLC22A1 and SLC22A2, respectively, for the Xhosa population from the information gathered with SNaPshot™ genotyping. This study highlights the fact that African populations do not have the same allele frequencies for SNPs in pharmacogenetically relevant genes. Furthermore, the Xhosa and other African populations do not share all reduced function variants of the SLC22A1-3 and SLC47A1 genes with Caucasian and Asian populations. Moreover, this study has demonstrated that the Xhosa population harbours novel and rare genetic polymorphisms in the key pharmacogene SLC22A2. This study lays the foundation for the design and interpretation of future pharmacogenetic association studies between the variant alleles of the SLC22A1-3 and SLC47A1 genes in the Xhosa population and drug disposition and efficacy.

Em bovinos de corte, maiores diâmetros do folículo pré-ovulatório (FPO) e as subsequentes altas concentrações de progesterona [P4] aumentam o crescimento do concepto e a taxa de prenhez. Formulou-se a hipótese que a modulação do tamanho do FPO e [P4] no diestro subsequente à ovulação do FPO estimulam a expressão endometrial de transcritos e proteínas da famílias das Solute Carrier Proteins (SLC) que estão relacionadas ao transporte de glicose. Vacas Nelore (n=60), solteiras e ciclando receberam duas injeções de PGF2&alpha; (PGF; 0,5mg; i.m.) com intervalo de 14 dias. Dez dias após (dia -10; D-10), receberam um dispositivo intravaginal liberador de P4 e benzoato de estradiol (2mg; i.m.). Para modular o crescimento do FPO e alterar a produção de P4 pós-ovulação, no D-10 os animais receberam PGF (grupo alta P4; AP) ou não (grupo baixa P4; BP). Dispositivos foram removidos e PGF injetada 60 a 42 horas antes da indução da ovulação para o grupo AP e 48 a 30 horas antes da indução para o grupo BP e ovulações foram induzidas com GnRH (buserelina; 10&micro;g; i.m.) no D0. Crescimento e ovulação do FPO e formação do CL foram avaliados por ultrassom e [P4] medidas por radioimunoensaio. No D7 os animais que ovularam foram abatidos (AP, N=18 e BP, N=18), o endométrio foi dissecado e submetido à extração de RNA total para análises de qPCR, extração de proteínas totais para análises de western blotting e incluído em parafina para análises de imunohistoquímica. Diferença entre as médias dos grupos foi determinada pelo teste t de student. O diâmetro máximo do FPO (média ± erro padrão da média; 12,8±0,4 vs. 11,1±0,4mm) foi maior no grupo AP (P<0,01). A [P4] no D7 foi maior no grupo AP (4,5±1,0 ng/mL vs. 3,3±1,1 ng/mL; P<0,05). As concentrações relativas dos transcritos que codificam SLCs foram determinadas por qPCR, usando a ciclofilina como controle endógeno. Não houve diferença na expressão de SLC2A1 (0,91±0,04 vs. 1,02±0,07), SLC2A3 (1,14±0,16 vs. 1,05±0,1), SLC2A4 (1,20±0,14 vs. 1,01±0,05), SLC2A5 (0,95±0,12 vs. 1,04±0,12), SLC5A1 (1,35±0,25 vs. 1,49±0,44), ATP1A2 (1,29±0,17 vs. 1,03±0,1), ATP1B2 (1,20±0,11 vs. 1,06±0,1), SLC37A4 (1,16±0,16 vs. 1,1±0,12), entre os grupos AP e BP respectivamente (P>0.05). Também não foi possível identificar diferença na quantidade proteica de SLC2A1 no endométrio dos animais do grupo AP em relação ao grupo BP. SLC2A1 foi identificada na membrana basal no epitélio luminal (EL), epitélio glandular (EG) e no estroma uterino dos animais. SLC2A4 foi identificada na membrana basal e membrana apical no EL, EG e no estroma uterino dos animais. Em conclusão, a modulação do tamanho do FPO e [P4] no diestro não afetaram a expressão gênica ou proteica dos transportadores de glicose. É possível que ao invés da expressão gênica ou proteica, a atividade transportadora das SLCs, ou ainda, a expressão e função de genes relacionados ao metabolismo de carboidratos, sejam regulados pelo ambiente endócrino peri-ovulatório em vacas. / In beef cattle, changes in the peri-ovulatory endocrine milieu are associated with conceptus growth and fertility. A large size of the pre-ovulatory follicle (POF) and resulting elevated progesterone (P4) concentrations during diestrus affect pregnancy rates positively. Our hypothesis is that modulation of POF size and diestrus P4 concentrations regulate nutrient availability in the uterus. Specifically, optimal glucose concentrations in the histotroph are required for adequate embryo growth during early gestation. The objective was to determine if POF size and resulting P4 concentrations during the first week of diestrus influence gene expression of Solute Carrier Protein (SLC) families that are related to glucose transport. Cyclic, non-lactating Nelore cows received two injections of cloprostenol (PGF; 0.5mg; i.m.) 14 days apart. Ten days later (day -10; D-10), cows received a P4-releasing device along with estradiol benzoate (2mg; i.m.). To modulate the growth of the POF and alter post-ovulatory P4 production, on D-10 animals received PGF (high post-ovulatory P4 group; HP) or not (low post-ovulatory P4 group; LP). The P4-releasing devices were removed and PGF injected 60 to 42 hours before the ovulation induction in the HP group and 48 to 30 hours before the ovulation induction in the LP group. Ovulation was induced with buserelin (GnRH; 10&micro;g; i.m.) on D0. Diameter of POF and ovulation were assessed by ultrasonography starting onD- 2. From D1 to D7, plasma was obtained for measurement of P4 concentration. On D7, cows that ovulated were slaughtered (HP, n=18 and LP, n=18) and endometrium was dissected and subjected total RNA extraction for qPCR analyzes, total protein extraction for western blotting analyzes and included in paraffin for imunohistochemical analyzes. Differences between group means were determined by student\'s t test. Maximum diameter of the POF (mean ± SEM; 12.8±0.4 vs. 11.1±0.4mm) was greater in HP vs. LP (P<0.01). Progesterone concentration on D7 was larger on the HP group (4.5±1.0 ng/mL and 3.3±1.1 ng/mL; P<0.05). Relative concentrations of transcripts coding for facilitative sugar transporters (SLC2A1, SLC2A3, SLC2A4 and SLC2A5), a sodium-dependent glucose co-transporter (SLC5A1) and other transporters related to glucose uptake (ATP1A2, ATP1B2, SLC37A4) were determined by qPCR, using cyclophilin as the endogenous control gene. There were no significant differences in expression of SLC2A1 (mean ± SEM;0.91±0.04 vs. 1.02±0.07), SLC2A3 (1.14±0.16 vs. 1.05±0.1), SLC2A4 (1.20±0.14 vs. 1.01±0.05), SLC2A5 (0.95±0.12 vs. 1.04±0.12), SLC5A1 (1.35±0.25 vs. 1.49±0.44), ATP1A2 (1.29±0.17 vs. 1.03±0.1), ATP1B2 (1.20±0.11 VS. 1.06±0.1) ,SLC37A4 (1.16±0.16 vs. 1.1±0.12), between HP and LP, respectively (P>0.05). There was no difference in the abundance of SLC2A1 protein between groups. The SLC2A1 protein was localized in the luminal epithelium (LE), glandular epithelium (GE) and uterine stroma (US) of animals. The SLC2A4 protein was localized on the basal and apical membrane of the LE, GE and US of animals. In conclusion, modulation of POF size and diestrus P4 concentrations did not affect the expression of glucose transporter genes or proteins. It is possible that activity of SLC proteins rather than gene expression, or alternatively, expression and function of genes related to carbohydrate metabolism, are regulated by the peri-ovulatory endocrine milieu in cows.

Em bovinos de corte, maiores diâmetros do folículo pré-ovulatório (FPO) e as subsequentes altas concentrações de progesterona [P4] aumentam o crescimento do concepto e a taxa de prenhez. Formulou-se a hipótese que a modulação do tamanho do FPO e [P4] no diestro subsequente à ovulação do FPO estimulam a expressão endometrial de transcritos e proteínas da famílias das Solute Carrier Proteins (SLC) que estão relacionadas ao transporte de glicose. Vacas Nelore (n=60), solteiras e ciclando receberam duas injeções de PGF2&alpha; (PGF; 0,5mg; i.m.) com intervalo de 14 dias. Dez dias após (dia -10; D-10), receberam um dispositivo intravaginal liberador de P4 e benzoato de estradiol (2mg; i.m.). Para modular o crescimento do FPO e alterar a produção de P4 pós-ovulação, no D-10 os animais receberam PGF (grupo alta P4; AP) ou não (grupo baixa P4; BP). Dispositivos foram removidos e PGF injetada 60 a 42 horas antes da indução da ovulação para o grupo AP e 48 a 30 horas antes da indução para o grupo BP e ovulações foram induzidas com GnRH (buserelina; 10&micro;g; i.m.) no D0. Crescimento e ovulação do FPO e formação do CL foram avaliados por ultrassom e [P4] medidas por radioimunoensaio. No D7 os animais que ovularam foram abatidos (AP, N=18 e BP, N=18), o endométrio foi dissecado e submetido à extração de RNA total para análises de qPCR, extração de proteínas totais para análises de western blotting e incluído em parafina para análises de imunohistoquímica. Diferença entre as médias dos grupos foi determinada pelo teste t de student. O diâmetro máximo do FPO (média ± erro padrão da média; 12,8±0,4 vs. 11,1±0,4mm) foi maior no grupo AP (P<0,01). A [P4] no D7 foi maior no grupo AP (4,5±1,0 ng/mL vs. 3,3±1,1 ng/mL; P<0,05). As concentrações relativas dos transcritos que codificam SLCs foram determinadas por qPCR, usando a ciclofilina como controle endógeno. Não houve diferença na expressão de SLC2A1 (0,91±0,04 vs. 1,02±0,07), SLC2A3 (1,14±0,16 vs. 1,05±0,1), SLC2A4 (1,20±0,14 vs. 1,01±0,05), SLC2A5 (0,95±0,12 vs. 1,04±0,12), SLC5A1 (1,35±0,25 vs. 1,49±0,44), ATP1A2 (1,29±0,17 vs. 1,03±0,1), ATP1B2 (1,20±0,11 vs. 1,06±0,1), SLC37A4 (1,16±0,16 vs. 1,1±0,12), entre os grupos AP e BP respectivamente (P>0.05). Também não foi possível identificar diferença na quantidade proteica de SLC2A1 no endométrio dos animais do grupo AP em relação ao grupo BP. SLC2A1 foi identificada na membrana basal no epitélio luminal (EL), epitélio glandular (EG) e no estroma uterino dos animais. SLC2A4 foi identificada na membrana basal e membrana apical no EL, EG e no estroma uterino dos animais. Em conclusão, a modulação do tamanho do FPO e [P4] no diestro não afetaram a expressão gênica ou proteica dos transportadores de glicose. É possível que ao invés da expressão gênica ou proteica, a atividade transportadora das SLCs, ou ainda, a expressão e função de genes relacionados ao metabolismo de carboidratos, sejam regulados pelo ambiente endócrino peri-ovulatório em vacas. / In beef cattle, changes in the peri-ovulatory endocrine milieu are associated with conceptus growth and fertility. A large size of the pre-ovulatory follicle (POF) and resulting elevated progesterone (P4) concentrations during diestrus affect pregnancy rates positively. Our hypothesis is that modulation of POF size and diestrus P4 concentrations regulate nutrient availability in the uterus. Specifically, optimal glucose concentrations in the histotroph are required for adequate embryo growth during early gestation. The objective was to determine if POF size and resulting P4 concentrations during the first week of diestrus influence gene expression of Solute Carrier Protein (SLC) families that are related to glucose transport. Cyclic, non-lactating Nelore cows received two injections of cloprostenol (PGF; 0.5mg; i.m.) 14 days apart. Ten days later (day -10; D-10), cows received a P4-releasing device along with estradiol benzoate (2mg; i.m.). To modulate the growth of the POF and alter post-ovulatory P4 production, on D-10 animals received PGF (high post-ovulatory P4 group; HP) or not (low post-ovulatory P4 group; LP). The P4-releasing devices were removed and PGF injected 60 to 42 hours before the ovulation induction in the HP group and 48 to 30 hours before the ovulation induction in the LP group. Ovulation was induced with buserelin (GnRH; 10&micro;g; i.m.) on D0. Diameter of POF and ovulation were assessed by ultrasonography starting onD- 2. From D1 to D7, plasma was obtained for measurement of P4 concentration. On D7, cows that ovulated were slaughtered (HP, n=18 and LP, n=18) and endometrium was dissected and subjected total RNA extraction for qPCR analyzes, total protein extraction for western blotting analyzes and included in paraffin for imunohistochemical analyzes. Differences between group means were determined by student\'s t test. Maximum diameter of the POF (mean ± SEM; 12.8±0.4 vs. 11.1±0.4mm) was greater in HP vs. LP (P<0.01). Progesterone concentration on D7 was larger on the HP group (4.5±1.0 ng/mL and 3.3±1.1 ng/mL; P<0.05). Relative concentrations of transcripts coding for facilitative sugar transporters (SLC2A1, SLC2A3, SLC2A4 and SLC2A5), a sodium-dependent glucose co-transporter (SLC5A1) and other transporters related to glucose uptake (ATP1A2, ATP1B2, SLC37A4) were determined by qPCR, using cyclophilin as the endogenous control gene. There were no significant differences in expression of SLC2A1 (mean ± SEM;0.91±0.04 vs. 1.02±0.07), SLC2A3 (1.14±0.16 vs. 1.05±0.1), SLC2A4 (1.20±0.14 vs. 1.01±0.05), SLC2A5 (0.95±0.12 vs. 1.04±0.12), SLC5A1 (1.35±0.25 vs. 1.49±0.44), ATP1A2 (1.29±0.17 vs. 1.03±0.1), ATP1B2 (1.20±0.11 VS. 1.06±0.1) ,SLC37A4 (1.16±0.16 vs. 1.1±0.12), between HP and LP, respectively (P>0.05). There was no difference in the abundance of SLC2A1 protein between groups. The SLC2A1 protein was localized in the luminal epithelium (LE), glandular epithelium (GE) and uterine stroma (US) of animals. The SLC2A4 protein was localized on the basal and apical membrane of the LE, GE and US of animals. In conclusion, modulation of POF size and diestrus P4 concentrations did not affect the expression of glucose transporter genes or proteins. It is possible that activity of SLC proteins rather than gene expression, or alternatively, expression and function of genes related to carbohydrate metabolism, are regulated by the peri-ovulatory endocrine milieu in cows.

Solute carriers (SLCs) comprise the largest group of transporters in humans and there are currently 52 SLC families. They are embedded in cellular membranes and transport numerous molecules; defects in many of the genes encoding SLCs have been connected to pathological conditions, and several SLCs are potential drug targets. The SLC38 family has in total eleven members in humans and they encode transporters called SNATs. In paper I and paper II, we reported molecular and functional characterization of Slc38a7 and Slc38a8, two of the previous orphan members in the family which we suggested to be named SNAT7 and SNAT8, respectively. Using in situ hybridization and immunohistochemistry, these transporters showed similar expression pattern and localized to neurons in the brain For functional characterization proteins were overexpressed in X. laevis oocytes and an Uptake Assay and electrophysiological recordings showed preferred transport of L-glutamine, L-histidine, L-alanine, L-asparagine, L-aspartate and L-arginine for SNAT7. A similar pattern was seen for SNAT8 in a slightly different order of affinities. We classified SNAT7 as a system N transporter and SNAT8 as belonging to system A, and suggests that SNAT7 and SNAT8 could play a role in the glutamine/glutamate(GABA) cycle (GGC) in the brain. Furthermore, we studied the vesicular B0AT3 (Slc6a17) transporter in paper III, and the sodium-coupled amino acid transporter B0AT2 (Slc6a15) in paper IV. Tissue expression studies showed similar localization of Slc6a17 and Slc6a15 mRNA using in situ hybridization and real-time PCR. In paper III, vesicular localization of B0AT2 was shown in both excitatory and inhibitory neurons. When challenging the monoaminergic system with drugs both Slc6a17 and Slc6a15 were upregulated. Suggested roles for the transporters are thereby in synaptic remodeling by regulating the availability of free amino acids used as precursors needed in neurotransmitter synthesis. Moreover, in paper IV, immunohistochemistry showed B0AT3 localization to neurons, astrocytes and epithelial cells of the choroid plexus. Leucine injections caused a smaller reduction of food intake as well as higher neuronal activation in the paraventricular hypothalamic nucleus in Slc6a15 KO mice, compared with wild type mice. This suggests B0AT2 involvement in the anorexigenic effects of leucine.

Fluoroquinolones (FQ) are broad-spectrum charged antimicrobials exhibiting excellent tissue/fluid permeation. Thus, FQ disposition depends essentially on active transport and facilitative diffusion. Although most early transporter studies investigating renal elimination of FQs have focused on apical efflux of FQs from renal proximal tubule cell (RPTC) into urine, their basolateral uptake mechanism(s) from blood into RPTC (i.e., first step to tubular secretion) has not yet been explored in detail. Renally expressed SLC22 members: organic anion (OATs) and cation (OCTs) transporters are known to transport such small organic ionic substrates (molecular weight ~400 Da). Hence it is of interest to explore the role of these basolateral transporters in renal elimination of FQs, and to further quantitatively assess their impact in clinically observed FQ drug-drug interactions (DDI). An initial systematic review of clinical literature for FQs (n=18) demonstrated substantial differences among their renal clearance (CLren~46-fold) and unbound renal clearance (CLrenu~20-fold), and suggested that tubular secretion and reabsorption could be major determinants of FQ half-life, efficacy, and DDIs. FQs (n=13) identified from the above review were investigated by in-vitro transport studies using stably transfected cell lines, for potential interactions with organic cation [human (h) OCT1, hOCT2 and hOCT3] and anion [mouse (m) and hOAT3, hOAT1; and hOAT4] transporters. Further, kinetic inhibition studies were conducted to determine inhibition potency (Ki/IC50 values) for those FQs exhibiting significant OCT/OAT inhibition in preliminary interaction experiments. Gatifloxacin, moxifloxacin, prulifloxacin, and sparfloxacin were determined to be competitive inhibitors of hOCT1 with Ki = 250±18, 161±19, 136±33, and 94±8 μM, respectively. Moxifloxacin competitively inhibited hOCT3-mediated uptake, Ki = 1,598±146 μM. Enoxacin, fleroxacin, levofloxacin, lomefloxacin, moxifloxacin, prulifloxacin, and sparfloxacin exhibited competitive inhibition for mOat3 with Ki = 396±15, 817±31, 515±22, 539±27, 1356±114, 299±35, 205±12 μM, respectively. Fleroxacin and pefloxacin were found to inhibit hOAT1 with IC50 = 2228±84 and 1819±144 respectively. Despite expression in enterocytes, hepatocytes, and RPTC, hOCT3 does not appear to contribute significantly to FQ disposition. However, due to hepatic and potential RPTC expression, hOCT1 could play an important role in elimination of these antimicrobials. Among renally expressed OATs in humans, hOAT1 and hOAT3 are likely to be involved in FQ elimination.

No description available.

Universiẗat, Diss., 2004--Köln.

Philosophiae Doctor - PhD / Solute carrier transporters belonging to the major facilitator family of membrane transporter are increasingly being recognized as a possible mechanism to explain inter-individual variation in drug efficacy and response. Genetic factors are estimated to be responsible for approximately 15-30% of inter-individual variation in drug disposition and response. The aims of this study were to determine the minor allele frequencies of 78 previously identified single nucleotide polymorphisms in the pharmacogenomically relevant SLC22A1-3 and SLCO1B1 genes in the Admixed population of South Africa. Thereafter, to determine whether allele and genotype frequencies for these SNP were different from that reported for other African, Caucasian, and Asian populations. The inferred haplotypes from the genetic information possessed the potential to subsequently be used in future to design and interpret results of pharmacogenomic association studies involving these genes and their substrate drugs. Furthermore, to determine whether the Cape Admixed population harbour novel SNPs in the proximal promoter regions of SLC22A1- 3 and SLCO1B1-3 genes, that encodes hOCT1-3 and hOATP1 and hOATP3, respectively. SNaPshot™ multiplex single base mini-sequencing systems were developed and optimized for each of SLC22A1, SLC22A2, SLC22A3, and SLCO1B1 genes covering the previously identified 78 SNPs. These systems were then used to genotype the alleles of 130 healthy Cape Admixed subjects residing in Cape Town, South Africa. In addition, the proximal promoter regions of the SLC22A1-3 and SLCO1B1-3 genes of 96 of the participants were screened for novel SNPs by direct sequencing. The Cape Admixed subjects investigated displayed a lack of variation and were monomorphic for 78% of the SNPs screened. None of the SLC22A3 SNPs investigated was observed in this study. Sequencing of the proximal promoter regions of the SLC22 and SLCO genes did not reveal any novel SNPs in the 96 Cape Admixed subjects that were screened. This study highlights the fact that African populations do not have the same allele frequencies for SNPs in harmacogenomically relevant genes. Furthermore, the Cape Admixed and other African populations do not share all reduced-function variants of the SLC22A1-3 and SLCO1B1-3 genes with Caucasian and Asian populations. In addition, previously identified novel regulatory variants in SLC22A2 did not exhibit a significant effect on the ability of the promoter to drive transcription. However, it must be noted that these results were observed at 95% confidence interval, and that a 99% confidence interval the significance may increase theoretically. Additionally, it should be noted that more intensive studies are required to determine the potential effect these novel variants may well cause. This study lays the foundation for the design and interpretation of future pharmacogenomic association studies between the variant alleles of the SLC22A and SLCO genes in the Cape Admixed population, as well as optimizations for future expression, and more importantly, drug transport assays with respect to drug disposition and efficacy. / National Research Foundation (NRF) and the Medical Research Council (MRC)

Em vacas de corte, folículos pré-ovulatórios (FPO) maiores, maiores concentrações de estradiol (E2) no proestro/estro e progesterona (P4) no diestro favorecem o crescimento do concepto e a fertilidade. Porém, os mecanismos mediados pelos esteroides femininos que influenciam a receptividade uterina ao embrião precisam ser esclarecidos. Os aminoácidos (AA) são componentes das secreções uterinas que são cruciais para a sobrevivência do embrião antes da implantação. A hipótese deste trabalho é que o tamanho do FPO e as concentrações de E2 e P4 modulam a abundância de transcritos relacionados ao transporte e metabolismo de AA no endométrio e afetam a concentração luminal de AA. Para isso, o crescimento folicular de vacas Nelore foi manipulado com o objetivo de formar dois grupos: FPO grande e CL grande (FG-CLG) e FPO pequeno e CL pequeno (FP-CLP). No Dia 4 (D4; Exp 1) e Dia 7 (D7; Exp 2) após a injeção de GnRH para indução da ovulação, foram coletados tecido endometrial e lavado uterino post-mortem. A abundância de transcritos foi avaliada por qRT-PCR e as concentrações de AA nos lavados foram quantificadas por HPLC. No Exp 1, o tamanho do FPO, concentrações plasmáticas de E2 no D-1 e de P4 no D4 foram 15,70mm&#177;0,43 vs. 11,31mm&#177;0,23 (p&lt;0,01), 2,44pg/ml&#177;0,19 vs. 0,65pg/ml (p&lt;0,01) e 1,40ng/ml&#177;0,23 vs. 0,80ng/ml&#177;0,10 (p&lt;0,01) para os grupos FG-CLG vs. FP-CLP, respectivamente. No Exp 2, o tamanho do FPO, concentrações plasmáticas de E2 no D-1 e de P4 no D7 foram 13,18mm&#177;0,44 vs. 10,63mm&#177;0,30 (p&lt;0,01), 2,30pg/ml&#177;0,57 vs. 0,50pg/ml&#177;0,13 (p&lt;0,01) e 3,68ng/ml&#177;0,38 vs. 2,49ng/ml&#177;0,43 (p=0,04) para os grupos FG-CLG vs. FP-CLP, respectivamente. No D4 a abundância de SLC1A4, SLC38A1, SLC6A6, SLC7A4 e SLCY e no D7, SLC1A4, SLC6A1, SLC6A14, SLC7A4, SLC7A8, SLC38A1, SLC38A7, SLC43A2 e DDO foi maior no endométrio dos animais do grupo FG-CLG (p&lt;0,05). No D4, maiores concentrações de taurina, alanina e ácido &#945;-aminobutírico foram observadas no grupo FP-CLP (p&lt;0,05). Em contraste, menores concentrações de valina e cistationina foram encontradas nos lavados uterinos do D7 dos animais do grupo FP-CLP (p&lt;0,05). No D4, os animais do grupo FG-CLG, associado a maior fertilidade, apresentaram menor quantidade de AA nas secreções uterinas, porém, a abundância dos transportadores de AA foi compatível com maior transporte em comparação aos animais do grupo FP-CLP. Esses resultados sugerem que antes do embrião se mover do oviduto ao útero, o transporte e metabolismo dos AA prioriza a preparação das células endometriais para receber o embrião e não o acúmulo nas secreções uterinas. Porém, no D7, quando o embrião está em contato direto com as secreções uterinas, os genes relacionados ao transporte de AA no endométrio e a concentração de AA no histotrofo são estimulados nas vacas do grupo FG-CLG. Portanto o metabolismo e transporte de AA no sentido das células endometriais ou das secreções uterinas pode ser um mecanismo importante para a receptividade materna. / In beef cattle, a large size of the pre-ovulatory follicle (POF) and resulting elevated proestrus/estrus estradiol (E2) and diestrus progesterone (P4) concentrations positively affect conceptus growth and fertility. However, sex-steroid-mediated mechanisms that influence uterine receptivity to the embryo need to be elucidated. Amino acids are important components of maternally-derived secretions that are crucial for embryo survival before implantation. The hypothesis is that the size of the POF, E2 and P4 concentrations modulate endometrial abundance of solute carrier proteins (SLC) transcripts related to AA transport and metabolism and subsequently affect lumenal amino acids concentrations. Therefore, follicle growth of Nelore cows was manipulated to produce two experimental groups: large POF and CL (LF-LCL group) and small POF and CL (SF-SCL group). On Day 4 (D4; Experiment 1) and Day 7 (D7; Experiment 2) post GnRH injection to induce ovulation, endometrial tissue and uterine washings were collected post-mortem. Transcript abundance was evaluated by qRT-PCR and amino acid concentrations were quantified in washings by HPLC. On Experiment 1, POF size, plasma E2 concentration on D-1, and plasma concentration of P4 on D4 were 15.70mm&#177;0.43 vs. 11.31mm&#177;0.23 (p&lt;0.01), 2.44pg/ml&#177;0.19 vs. 0.65pg/ml (p&lt;0.01) and 1.40ng/ml&#177;0.23 vs. 0.80ng/ml&#177;0.10 (p&lt;0.01) for the LF-LCL vs. SF-SCL groups, respectively. For Experiment 2, POF size, plasma E2 concentration on D-1 and plasma P4 concentration on D7 were 13.18mm&#177;0.44 vs. 10.63mm&#177;0.30 (p&lt;0.01), 2.30pg/ml&#177;0.57 vs. 0.50pg/ml&#177;0.13 (p&lt;0.01) and 3.68ng/ml&#177;0.38 vs. 2.49ng/ml&#177;0.43 (p=0.04) for the LF-LCL vs. SF-SCL groups, respectively. On D4, abundance of SLC6A6, SLC7A4, SLC17A5, SLC38A1, SLC38A7 and SLCY and on D7, SLC1A4, SLC6A1, SLC6A14, SLC7A4, SLC7A7, SLC7A8, SLC17A5, SLC38A1, SLC38A7, SLC43A2 and DDO was greater in the endometrium of cows from the LF-LCL group (p&lt;0.05). On D4, higher concentrations of taurine, alanine and &#945;-aminobutiric acid were observed in SF-SCL (p&lt;0.05). In contrast, lower concentrations of valine and cystathionine were quantified in D7 uterine washings from SF-SCL cows (p&lt;0.05). On D4, animals from LF-LCL group, associated with greater fertility, presented less amino acid content in uterine secretion but abundance of transporters was compatible to greater transport in comparison to animals from SF-SCL group. This suggests that before embryo moves from oviduct to uterus, amino acids transport and metabolism pathways prioritizes endometrium cells preparation for receiving the embryo but not accumulation in uterine secretions. However, on D7, when the embryo is in direct contact with uterine secretions, genes related to amino acids transport in endometrium and amino acids concentration in histotroph are up-regulated in LF-LCL cows. The latter insights indicate that amino acids metabolism and transport, towards endometrial cells or uterine secretions, might be mechanisms contributing to maternal receptivity.

Em vacas de corte, folículos pré-ovulatórios (FPO) maiores, maiores concentrações de estradiol (E2) no proestro/estro e progesterona (P4) no diestro favorecem o crescimento do concepto e a fertilidade. Porém, os mecanismos mediados pelos esteroides femininos que influenciam a receptividade uterina ao embrião precisam ser esclarecidos. Os aminoácidos (AA) são componentes das secreções uterinas que são cruciais para a sobrevivência do embrião antes da implantação. A hipótese deste trabalho é que o tamanho do FPO e as concentrações de E2 e P4 modulam a abundância de transcritos relacionados ao transporte e metabolismo de AA no endométrio e afetam a concentração luminal de AA. Para isso, o crescimento folicular de vacas Nelore foi manipulado com o objetivo de formar dois grupos: FPO grande e CL grande (FG-CLG) e FPO pequeno e CL pequeno (FP-CLP). No Dia 4 (D4; Exp 1) e Dia 7 (D7; Exp 2) após a injeção de GnRH para indução da ovulação, foram coletados tecido endometrial e lavado uterino post-mortem. A abundância de transcritos foi avaliada por qRT-PCR e as concentrações de AA nos lavados foram quantificadas por HPLC. No Exp 1, o tamanho do FPO, concentrações plasmáticas de E2 no D-1 e de P4 no D4 foram 15,70mm&#177;0,43 vs. 11,31mm&#177;0,23 (p&lt;0,01), 2,44pg/ml&#177;0,19 vs. 0,65pg/ml (p&lt;0,01) e 1,40ng/ml&#177;0,23 vs. 0,80ng/ml&#177;0,10 (p&lt;0,01) para os grupos FG-CLG vs. FP-CLP, respectivamente. No Exp 2, o tamanho do FPO, concentrações plasmáticas de E2 no D-1 e de P4 no D7 foram 13,18mm&#177;0,44 vs. 10,63mm&#177;0,30 (p&lt;0,01), 2,30pg/ml&#177;0,57 vs. 0,50pg/ml&#177;0,13 (p&lt;0,01) e 3,68ng/ml&#177;0,38 vs. 2,49ng/ml&#177;0,43 (p=0,04) para os grupos FG-CLG vs. FP-CLP, respectivamente. No D4 a abundância de SLC1A4, SLC38A1, SLC6A6, SLC7A4 e SLCY e no D7, SLC1A4, SLC6A1, SLC6A14, SLC7A4, SLC7A8, SLC38A1, SLC38A7, SLC43A2 e DDO foi maior no endométrio dos animais do grupo FG-CLG (p&lt;0,05). No D4, maiores concentrações de taurina, alanina e ácido &#945;-aminobutírico foram observadas no grupo FP-CLP (p&lt;0,05). Em contraste, menores concentrações de valina e cistationina foram encontradas nos lavados uterinos do D7 dos animais do grupo FP-CLP (p&lt;0,05). No D4, os animais do grupo FG-CLG, associado a maior fertilidade, apresentaram menor quantidade de AA nas secreções uterinas, porém, a abundância dos transportadores de AA foi compatível com maior transporte em comparação aos animais do grupo FP-CLP. Esses resultados sugerem que antes do embrião se mover do oviduto ao útero, o transporte e metabolismo dos AA prioriza a preparação das células endometriais para receber o embrião e não o acúmulo nas secreções uterinas. Porém, no D7, quando o embrião está em contato direto com as secreções uterinas, os genes relacionados ao transporte de AA no endométrio e a concentração de AA no histotrofo são estimulados nas vacas do grupo FG-CLG. Portanto o metabolismo e transporte de AA no sentido das células endometriais ou das secreções uterinas pode ser um mecanismo importante para a receptividade materna. / In beef cattle, a large size of the pre-ovulatory follicle (POF) and resulting elevated proestrus/estrus estradiol (E2) and diestrus progesterone (P4) concentrations positively affect conceptus growth and fertility. However, sex-steroid-mediated mechanisms that influence uterine receptivity to the embryo need to be elucidated. Amino acids are important components of maternally-derived secretions that are crucial for embryo survival before implantation. The hypothesis is that the size of the POF, E2 and P4 concentrations modulate endometrial abundance of solute carrier proteins (SLC) transcripts related to AA transport and metabolism and subsequently affect lumenal amino acids concentrations. Therefore, follicle growth of Nelore cows was manipulated to produce two experimental groups: large POF and CL (LF-LCL group) and small POF and CL (SF-SCL group). On Day 4 (D4; Experiment 1) and Day 7 (D7; Experiment 2) post GnRH injection to induce ovulation, endometrial tissue and uterine washings were collected post-mortem. Transcript abundance was evaluated by qRT-PCR and amino acid concentrations were quantified in washings by HPLC. On Experiment 1, POF size, plasma E2 concentration on D-1, and plasma concentration of P4 on D4 were 15.70mm&#177;0.43 vs. 11.31mm&#177;0.23 (p&lt;0.01), 2.44pg/ml&#177;0.19 vs. 0.65pg/ml (p&lt;0.01) and 1.40ng/ml&#177;0.23 vs. 0.80ng/ml&#177;0.10 (p&lt;0.01) for the LF-LCL vs. SF-SCL groups, respectively. For Experiment 2, POF size, plasma E2 concentration on D-1 and plasma P4 concentration on D7 were 13.18mm&#177;0.44 vs. 10.63mm&#177;0.30 (p&lt;0.01), 2.30pg/ml&#177;0.57 vs. 0.50pg/ml&#177;0.13 (p&lt;0.01) and 3.68ng/ml&#177;0.38 vs. 2.49ng/ml&#177;0.43 (p=0.04) for the LF-LCL vs. SF-SCL groups, respectively. On D4, abundance of SLC6A6, SLC7A4, SLC17A5, SLC38A1, SLC38A7 and SLCY and on D7, SLC1A4, SLC6A1, SLC6A14, SLC7A4, SLC7A7, SLC7A8, SLC17A5, SLC38A1, SLC38A7, SLC43A2 and DDO was greater in the endometrium of cows from the LF-LCL group (p&lt;0.05). On D4, higher concentrations of taurine, alanine and &#945;-aminobutiric acid were observed in SF-SCL (p&lt;0.05). In contrast, lower concentrations of valine and cystathionine were quantified in D7 uterine washings from SF-SCL cows (p&lt;0.05). On D4, animals from LF-LCL group, associated with greater fertility, presented less amino acid content in uterine secretion but abundance of transporters was compatible to greater transport in comparison to animals from SF-SCL group. This suggests that before embryo moves from oviduct to uterus, amino acids transport and metabolism pathways prioritizes endometrium cells preparation for receiving the embryo but not accumulation in uterine secretions. However, on D7, when the embryo is in direct contact with uterine secretions, genes related to amino acids transport in endometrium and amino acids concentration in histotroph are up-regulated in LF-LCL cows. The latter insights indicate that amino acids metabolism and transport, towards endometrial cells or uterine secretions, might be mechanisms contributing to maternal receptivity.